
Vigabatrin in Drug-Resistant Epilepsy
Abstract
A double-blind, placebo-controlled, crossover study of oral Vigabatrin (2-3 g/d) as add-on therapy for 31 patients with drug-resistant seizures is reported from the Neurological Clinic, Univ of Bologna School of Med, Italy.
DOI: https://doi.org/10.15844/pedneurbriefs-1-5-4 | Journal eISSN: 2166-6482
Language: English
Page range: 33 - 34
Published on: Oct 1, 1987
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1987 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.